Hunan Er Kang Pharmaceutical (300267) — Tangible Net Worth Ratio
Hunan Er Kang Pharmaceutical (300267) has a Tangible Net Worth Ratio of 92.0% as of June 2025. This metric is calculated by deducting intangible assets (CN¥353.85 Million) from net assets (CN¥4.42 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Hunan Er Kang Pharmaceutical net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hunan Er Kang Pharmaceutical Tangible Net Worth Ratio (2008–2024)
This chart shows how Hunan Er Kang Pharmaceutical's Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 92.0%, reflecting net assets of CN¥4.42 Billion with intangible assets of CN¥353.85 Million CNY. Also explore 300267 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hunan Er Kang Pharmaceutical (2008–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Hunan Er Kang Pharmaceutical from 2008 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Hunan Er Kang Pharmaceutical.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.7% | CN¥4.40 Billion | CN¥363.56 Million | CN¥5.20 Billion | ▼ -0.4 pp |
| 2023 | 92.1% | CN¥4.81 Billion | CN¥378.03 Million | CN¥5.48 Billion | ▲ +0.2 pp |
| 2022 | 92.0% | CN¥5.05 Billion | CN¥406.14 Million | CN¥5.86 Billion | ▲ +0.8 pp |
| 2021 | 91.1% | CN¥4.87 Billion | CN¥431.45 Million | CN¥5.43 Billion | ▲ +0.2 pp |
| 2020 | 90.9% | CN¥5.79 Billion | CN¥525.23 Million | CN¥6.55 Billion | ▼ -2.5 pp |
| 2019 | 93.4% | CN¥5.79 Billion | CN¥382.56 Million | CN¥6.14 Billion | ▼ -2.1 pp |
| 2018 | 95.5% | CN¥5.64 Billion | CN¥254.67 Million | CN¥6.05 Billion | ▲ +0.4 pp |
| 2017 | 95.1% | CN¥5.41 Billion | CN¥265.93 Million | CN¥5.72 Billion | ▲ +0.1 pp |
| 2016 | 95.0% | CN¥5.24 Billion | CN¥263.92 Million | CN¥5.65 Billion | ▲ +0.3 pp |
| 2015 | 94.7% | CN¥4.26 Billion | CN¥225.93 Million | CN¥4.80 Billion | ▲ +6.2 pp |
| 2014 | 88.5% | CN¥1.68 Billion | CN¥192.41 Million | CN¥2.22 Billion | ▼ -9.0 pp |
| 2013 | 97.5% | CN¥1.33 Billion | CN¥32.83 Million | CN¥1.45 Billion | ▼ -0.9 pp |
| 2012 | 98.5% | CN¥1.16 Billion | CN¥17.86 Million | CN¥1.24 Billion | ▼ -0.2 pp |
| 2011 | 98.7% | CN¥1.06 Billion | CN¥13.74 Million | CN¥1.13 Billion | ▲ +10.6 pp |
| 2010 | 88.1% | CN¥176.62 Million | CN¥20.98 Million | CN¥295.77 Million | ▲ +6.7 pp |
| 2009 | 81.4% | CN¥110.01 Million | CN¥20.41 Million | CN¥185.73 Million | ▼ -1.7 pp |
| 2008 | 83.1% | CN¥63.01 Million | CN¥10.64 Million | CN¥122.38 Million | — |